NO20025720L - Nye forbindelser med antibakteriell, soppdrepende eller antitumoraktivitet - Google Patents
Nye forbindelser med antibakteriell, soppdrepende eller antitumoraktivitetInfo
- Publication number
- NO20025720L NO20025720L NO20025720A NO20025720A NO20025720L NO 20025720 L NO20025720 L NO 20025720L NO 20025720 A NO20025720 A NO 20025720A NO 20025720 A NO20025720 A NO 20025720A NO 20025720 L NO20025720 L NO 20025720L
- Authority
- NO
- Norway
- Prior art keywords
- antifungal
- antibacterial
- antitumor activity
- new compounds
- antitumor
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
- C07D209/42—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyrrole Compounds (AREA)
- Indole Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US21447800P | 2000-06-27 | 2000-06-27 | |
PCT/US2001/020334 WO2002000650A2 (en) | 2000-06-27 | 2001-06-26 | Novel compounds possessing antibacterial, antifungal or antitumor activity |
Publications (2)
Publication Number | Publication Date |
---|---|
NO20025720D0 NO20025720D0 (no) | 2002-11-28 |
NO20025720L true NO20025720L (no) | 2003-02-26 |
Family
ID=22799223
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20025720A NO20025720L (no) | 2000-06-27 | 2002-11-28 | Nye forbindelser med antibakteriell, soppdrepende eller antitumoraktivitet |
Country Status (15)
Country | Link |
---|---|
US (2) | US6849713B2 (ru) |
EP (1) | EP1294713A2 (ru) |
JP (1) | JP2004501915A (ru) |
KR (1) | KR20030011371A (ru) |
CN (1) | CN1439006A (ru) |
AU (1) | AU2001270183A1 (ru) |
BR (1) | BR0112030A (ru) |
CA (1) | CA2414512A1 (ru) |
IL (1) | IL153119A0 (ru) |
MX (1) | MXPA02012271A (ru) |
NO (1) | NO20025720L (ru) |
NZ (1) | NZ522839A (ru) |
RU (1) | RU2003101969A (ru) |
WO (1) | WO2002000650A2 (ru) |
ZA (1) | ZA200209774B (ru) |
Families Citing this family (59)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7122626B2 (en) | 2001-04-26 | 2006-10-17 | Genesoft Pharmceuticals, Inc. | Halogen-substitued thienyl compounds |
US6825228B2 (en) | 2001-06-13 | 2004-11-30 | Genesoft Pharmaceuticals, Inc. | Benzothiophene compounds having antiinfective activity |
AU2002312370A1 (en) | 2001-06-13 | 2002-12-23 | Roland W. Burli | Antipathogenic benzamide compounds |
ITTO20010633A1 (it) * | 2001-07-02 | 2003-01-02 | Univ Ferrara | Nuovo impiego di poliammidi eterocicliche e benzoeterocicliche strutturalmente correlate all'antibiotico naturale distamicina a. |
GB0130868D0 (en) | 2001-12-24 | 2002-02-06 | Univ Strathclyde | New compounds |
BR0207583A (pt) * | 2001-12-26 | 2004-04-27 | Genelabs Tech Inc | Derivados de poliamida possuindo atividade antibacteriana, antifungo ou antitumor |
ITMI20021455A1 (it) * | 2002-07-02 | 2004-01-02 | Ugo Raffaello Citernesi | Formulazioni fosfolipidiche di lexitropsine loro preparazione ed impiego terapeutico |
DE60326735D1 (de) | 2002-08-02 | 2009-04-30 | Genesoft Pharmaceuticals Inc | Biaryl-verbindungen mit antiinfektiver wirkung |
WO2004026264A2 (en) * | 2002-09-20 | 2004-04-01 | Genelabs Technologies, Inc. | Novel aromatic compounds possessing antifungal or antibacterial activity |
US20050215614A1 (en) * | 2002-10-15 | 2005-09-29 | Rigel Pharmaceuticals, Inc. | Substituted indoles and their use as hcv inhibitors |
US7265129B2 (en) | 2002-10-25 | 2007-09-04 | Genesoft Pharmaceuticals, Inc. | Anti-infective biaryl compounds |
AU2003297822A1 (en) | 2002-12-10 | 2004-06-30 | Oscient Pharmaceuticals Corporation | Antibacterial compounds having a (pyrrole carboxamide)-(benzamide)-(imidazole carboxamide) motif |
CA2524274A1 (en) * | 2003-05-02 | 2004-11-18 | Elan Pharmaceuticals, Inc. | 4-bromo-5-(2-chloro-benzoylamino)-1h-pyrazole-3-carboxylic acid (1-(aminocarbonyl)eth-1-yl) amide derivatives and related compounds as bradykinin b1 receptor antagonists for the treatment of inflammatory diseases |
JP2006526015A (ja) * | 2003-05-02 | 2006-11-16 | エラン ファーマシューティカルズ,インコーポレイテッド | 炎症疾患治療のためのブラジキニンb1受容体アンタゴニストとしての4−ブロモ−5−(2−クロロ−ベンゾイルアミノ)−1h−ピラゾール−3−カルボン酸アミド誘導体および関連化合物 |
EP1635821B1 (en) * | 2003-05-02 | 2009-07-08 | Elan Pharmaceuticals, Inc. | 4-bromo-5-(2-chloro-benzoylamino)-1h-pyrazole-3-carboxylic acid (phenyl)amide derivatives and related compounds as bradykinin b1 receptor antagonists for the treatment of inflammatory diseases |
WO2006068760A2 (en) * | 2004-11-19 | 2006-06-29 | The Regents Of The University Of California | Anti-inflammatory pyrazolopyrimidines |
WO2008127226A2 (en) * | 2006-04-04 | 2008-10-23 | The Regents Of The University Of California | P13 kinase antagonists |
CN101511828A (zh) * | 2006-09-06 | 2009-08-19 | 霍夫曼-拉罗奇有限公司 | 作为蛋白激酶抑制剂的杂芳基衍生物 |
GB0619325D0 (en) | 2006-09-30 | 2006-11-08 | Univ Strathclyde | New compounds |
WO2009046448A1 (en) | 2007-10-04 | 2009-04-09 | Intellikine, Inc. | Chemical entities and therapeutic uses thereof |
KR101897881B1 (ko) * | 2008-01-04 | 2018-09-12 | 인텔리카인, 엘엘씨 | 특정 화학 물질, 조성물 및 방법 |
US8193182B2 (en) * | 2008-01-04 | 2012-06-05 | Intellikine, Inc. | Substituted isoquinolin-1(2H)-ones, and methods of use thereof |
JP5547099B2 (ja) * | 2008-03-14 | 2014-07-09 | インテリカイン, エルエルシー | キナーゼ阻害剤および使用方法 |
US8993580B2 (en) * | 2008-03-14 | 2015-03-31 | Intellikine Llc | Benzothiazole kinase inhibitors and methods of use |
CN102124009B (zh) | 2008-07-08 | 2014-07-23 | 因特利凯公司 | 激酶抑制剂及其使用方法 |
US20110224223A1 (en) * | 2008-07-08 | 2011-09-15 | The Regents Of The University Of California, A California Corporation | MTOR Modulators and Uses Thereof |
US8273900B2 (en) | 2008-08-07 | 2012-09-25 | Novartis Ag | Organic compounds |
JP5731978B2 (ja) | 2008-09-26 | 2015-06-10 | インテリカイン, エルエルシー | 複素環キナーゼ阻害剤 |
US8697709B2 (en) | 2008-10-16 | 2014-04-15 | The Regents Of The University Of California | Fused ring heteroaryl kinase inhibitors |
US8476282B2 (en) * | 2008-11-03 | 2013-07-02 | Intellikine Llc | Benzoxazole kinase inhibitors and methods of use |
CA2760791C (en) | 2009-05-07 | 2017-06-20 | Intellikine, Inc. | Heterocyclic compounds and uses thereof |
WO2011047384A2 (en) | 2009-10-16 | 2011-04-21 | The Regents Of The University Of California | Methods of inhibiting ire1 |
WO2011146882A1 (en) | 2010-05-21 | 2011-11-24 | Intellikine, Inc. | Chemical compounds, compositions and methods for kinase modulation |
CA2817577A1 (en) | 2010-11-10 | 2012-05-18 | Infinity Pharmaceuticals, Inc. | Heterocyclic compounds and uses thereof |
KR101875720B1 (ko) | 2011-01-10 | 2018-07-09 | 인피니티 파마슈티칼스, 인코포레이티드 | 이소퀴놀린온 및 이의 고체 형태의 제조 방법 |
CN106619647A (zh) | 2011-02-23 | 2017-05-10 | 因特利凯有限责任公司 | 激酶抑制剂的组合及其用途 |
KR20140063605A (ko) | 2011-07-19 | 2014-05-27 | 인피니티 파마슈티칼스, 인코포레이티드 | 헤테로사이클릭 화합물 및 그의 용도 |
JP6027610B2 (ja) | 2011-07-19 | 2016-11-16 | インフィニティー ファーマシューティカルズ, インコーポレイテッド | 複素環式化合物及びその使用 |
CN102952062B (zh) * | 2011-08-12 | 2016-06-08 | 中国医学科学院医药生物技术研究所 | 取代苯并杂环类化合物及其制备方法和应用 |
AR091790A1 (es) | 2011-08-29 | 2015-03-04 | Infinity Pharmaceuticals Inc | Derivados de isoquinolin-1-ona y sus usos |
MX370814B (es) | 2011-09-02 | 2020-01-08 | Univ California | Pirazolo[3,4-d]pirimidinas sustituidas y usos de las mismas. |
US8940742B2 (en) | 2012-04-10 | 2015-01-27 | Infinity Pharmaceuticals, Inc. | Heterocyclic compounds and uses thereof |
US8921426B2 (en) | 2012-04-18 | 2014-12-30 | International Business Machines Corporation | Cationic bis-urea compounds as effective antimicrobial agents |
US8828998B2 (en) | 2012-06-25 | 2014-09-09 | Infinity Pharmaceuticals, Inc. | Treatment of lupus, fibrotic conditions, and inflammatory myopathies and other disorders using PI3 kinase inhibitors |
EP2900673A4 (en) | 2012-09-26 | 2016-10-19 | Univ California | MODULATION OF IRE1 |
US9481667B2 (en) | 2013-03-15 | 2016-11-01 | Infinity Pharmaceuticals, Inc. | Salts and solid forms of isoquinolinones and composition comprising and methods of using the same |
EP3052485B1 (en) | 2013-10-04 | 2021-07-28 | Infinity Pharmaceuticals, Inc. | Heterocyclic compounds and uses thereof |
US9751888B2 (en) | 2013-10-04 | 2017-09-05 | Infinity Pharmaceuticals, Inc. | Heterocyclic compounds and uses thereof |
EP4066834A1 (en) | 2014-03-19 | 2022-10-05 | Infinity Pharmaceuticals, Inc. | Heterocyclic compounds for use in the treatment of pi3k-gamma mediated disorders |
US20150320755A1 (en) | 2014-04-16 | 2015-11-12 | Infinity Pharmaceuticals, Inc. | Combination therapies |
US9708348B2 (en) | 2014-10-03 | 2017-07-18 | Infinity Pharmaceuticals, Inc. | Trisubstituted bicyclic heterocyclic compounds with kinase activities and uses thereof |
CN104845967B (zh) | 2015-04-15 | 2020-12-11 | 苏州新海生物科技股份有限公司 | 寡聚核苷酸片段及使用其的选择性扩增目标核酸序列变异体的方法及应用 |
CN108026027B (zh) * | 2015-08-17 | 2020-10-02 | 邱浩杰 | 经取代的丙二酰胺化合物及其作为抗菌药物的用途 |
EP3350183A1 (en) | 2015-09-14 | 2018-07-25 | Infinity Pharmaceuticals, Inc. | Solid forms of isoquinolinone derivatives, process of making, compositions comprising, and methods of using the same |
US10759806B2 (en) | 2016-03-17 | 2020-09-01 | Infinity Pharmaceuticals, Inc. | Isotopologues of isoquinolinone and quinazolinone compounds and uses thereof as PI3K kinase inhibitors |
US10919914B2 (en) | 2016-06-08 | 2021-02-16 | Infinity Pharmaceuticals, Inc. | Heterocyclic compounds and uses thereof |
CN109640999A (zh) | 2016-06-24 | 2019-04-16 | 无限药品股份有限公司 | 组合疗法 |
WO2018047148A1 (en) | 2016-09-12 | 2018-03-15 | Novartis Ag | Compounds for the inhibition of mirna |
CN106832175B (zh) * | 2017-02-17 | 2019-10-18 | 华南理工大学 | 一种基于咔唑衍生物的双羟基荧光扩链剂及其制备与应用 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4107288A (en) * | 1974-09-18 | 1978-08-15 | Pharmaceutical Society Of Victoria | Injectable compositions, nanoparticles useful therein, and process of manufacturing same |
CA1308516C (en) * | 1987-07-06 | 1992-10-06 | J. William Lown | Oligopeptide anticancer and antiviral agents |
US5145684A (en) * | 1991-01-25 | 1992-09-08 | Sterling Drug Inc. | Surface modified drug nanoparticles |
WO1994007514A1 (en) * | 1992-09-29 | 1994-04-14 | Inhale Therapeutic Systems | Pulmonary delivery of active fragments of parathyroid hormone |
AU7380294A (en) * | 1993-08-06 | 1995-02-28 | Synphar Laboratories, Inc. | Oligopeptide antiretroviral agents |
US5502068A (en) * | 1995-01-31 | 1996-03-26 | Synphar Laboratories, Inc. | Cyclopropylpyrroloindole-oligopeptide anticancer agents |
-
2001
- 2001-06-26 IL IL15311901A patent/IL153119A0/xx unknown
- 2001-06-26 EP EP01948740A patent/EP1294713A2/en not_active Withdrawn
- 2001-06-26 JP JP2002505774A patent/JP2004501915A/ja not_active Withdrawn
- 2001-06-26 RU RU2003101969/04A patent/RU2003101969A/ru not_active Application Discontinuation
- 2001-06-26 NZ NZ522839A patent/NZ522839A/en unknown
- 2001-06-26 CN CN01811885A patent/CN1439006A/zh active Pending
- 2001-06-26 MX MXPA02012271A patent/MXPA02012271A/es unknown
- 2001-06-26 CA CA002414512A patent/CA2414512A1/en not_active Abandoned
- 2001-06-26 KR KR1020027017685A patent/KR20030011371A/ko not_active Application Discontinuation
- 2001-06-26 US US09/892,327 patent/US6849713B2/en not_active Expired - Fee Related
- 2001-06-26 WO PCT/US2001/020334 patent/WO2002000650A2/en not_active Application Discontinuation
- 2001-06-26 BR BR0112030-1A patent/BR0112030A/pt not_active IP Right Cessation
- 2001-06-26 AU AU2001270183A patent/AU2001270183A1/en not_active Abandoned
-
2002
- 2002-10-23 US US10/277,666 patent/US6906103B2/en not_active Expired - Fee Related
- 2002-11-28 NO NO20025720A patent/NO20025720L/no not_active Application Discontinuation
- 2002-12-02 ZA ZA200209774A patent/ZA200209774B/en unknown
Also Published As
Publication number | Publication date |
---|---|
WO2002000650A2 (en) | 2002-01-03 |
IL153119A0 (en) | 2003-06-24 |
WO2002000650A3 (en) | 2002-10-24 |
CA2414512A1 (en) | 2002-01-03 |
JP2004501915A (ja) | 2004-01-22 |
EP1294713A2 (en) | 2003-03-26 |
US20020037856A1 (en) | 2002-03-28 |
NZ522839A (en) | 2004-11-26 |
ZA200209774B (en) | 2004-03-02 |
US6849713B2 (en) | 2005-02-01 |
CN1439006A (zh) | 2003-08-27 |
NO20025720D0 (no) | 2002-11-28 |
KR20030011371A (ko) | 2003-02-07 |
US6906103B2 (en) | 2005-06-14 |
AU2001270183A1 (en) | 2002-01-08 |
RU2003101969A (ru) | 2004-07-10 |
BR0112030A (pt) | 2003-04-29 |
WO2002000650A9 (en) | 2003-03-06 |
US20030119749A1 (en) | 2003-06-26 |
MXPA02012271A (es) | 2004-09-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20025720D0 (no) | Nye forbindelser med antibakteriell, soppdrepende eller antitumoraktivitet | |
NO20023516L (no) | Antibakterielle 3-aminokinazolinon-2,4-dioner | |
NO20033773D0 (no) | Polyamidderivater med antibakteriell, antisopp- eller antitumor-aktivitet | |
DE60230054D1 (de) | 1h-imidazol-derivate mit cb1-agonistischer, antagonistischer oder partialer agonistischer aktivität | |
PT1140840E (pt) | Difenilureias substituidas com (.)-carboxiarilo como inibidores de raf-quinase | |
DE60017270D1 (de) | Serielle, lippenförmige rückschlagventile | |
NO20010916D0 (no) | Nye antibakterielle isoksazolinoner | |
IS8147A (is) | Nýjar línkómýsín afleiður sem búa yfir örverueyðandi virkni | |
DE50213548D1 (de) | Substituierte 2-carba-3,5-dicyano-4-aryl-6-aminopylektive liganden | |
BR0208971B1 (pt) | produto absorvente com ajuste melhorado. | |
BR0208970B1 (pt) | produto absorvente com ajuste melhorado. | |
NO20020810D0 (no) | Nye fenylpiperaziner | |
BR0208969B1 (pt) | produto absorvente com ajuste melhorado. | |
BR0013417B1 (pt) | composiÇço aquosa. | |
NO20030100L (no) | Pleuromutilinderivater som har antibakteriell aktivitet | |
PT1389213E (pt) | Formulacoes de 3,7-diazabiciclo 3,3,1¿ como compostos antiarritmicos | |
DE60129750D1 (de) | Antiblend-, antibeschlagselement | |
PT1206476E (pt) | 9a-azalidos com actividade antibacteriana | |
NL1021302A1 (nl) | Rolschakelaar. | |
DK1268475T3 (da) | Nye benzosultam-oxazolidinoner som antibakterielle midler | |
RU2003110288A (ru) | Вещество, обладающее антидепрессивной активностью | |
DE60041110D1 (de) | 6-Hydroxy-5,6-dihydrouracile als Herbizide | |
AR027978A1 (es) | 4-oxo-1,4-dihidro-3-cinolincarboxamidas como agentes antivirales | |
NO20025101D0 (no) | Nye, heterosykliske forbindelser med antiinflammatorisk aktivitet | |
DE69932256D1 (de) | Elektroluminiszierendes, organisches element |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |